Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Efficacy evaluation and safety analysis of TACE combined with HIFU in the treatment of liver metastases unresectable colorectal cancer

ABSTRACT: Interventions: experimental group:TACE+HIFU;control group: TACE Primary outcome(s): ORR Study Design: Parallel

DISEASE(S): Colorectal Cancer

PROVIDER: 2697767 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Clinical study of pembrolizumab combined with DEB-TACE in unresectable MSI-H/dMMR colorectal cancer liver metastasis

Project description:Interventions: Experimental group:Pembrolizumab + DEB-TACE Primary outcome(s): objective response rate Study Design: Single arm

| 37109 | ecrin-mdr-crc

Clinical study for detoxification and dispersal herbs combined with TACE in the treatment of unresectable liver metastasis of colorectal cancer and its correlation with exogenous microRNAs

Project description:Interventions: experimental group:detoxification and dispersal herbs combined with TACE ;control group:placebo (herb) combined with TACE Primary outcome(s): PFS Study Design: Parallel

| 2686364 | ecrin-mdr-crc

Phosphorylation of iRhom2 controls stimulated proteolytic shedding by the metalloprotease ADAM17/TACE

Project description:TACE (TNFa Converting Enzyme), is responsible for cleavage (‘shedding’) of membrane-tethered signaling molecules such as TNF of EGFR ligands. TACE interacts with iRhom2, which mediates the exit of TACE from the endoplasmic reticulum. In this study we analyze a new role for iRHOM2, where a fraction of the protein remains in the membrane and the phosphorylation of different residues in its cytoplasmatic tail is necessary for TACE shedding function.

2021-11-03 | PXD007763 | Pride

A Positive Feedback Loop Between TKT and c-Myc Drives TACE Resistance In Hepatocellular Carcinoma

Project description:Hepatocellular carcinoma (HCC) often receives transarterial chemoembolization (TACE), yet clinical benefit is limited by resistance driven by ischemia-induced adaptations. This study explains how transketolase (TKT) in the pentose phosphate pathway (PPP) modulates HCC progression and TACE refractoriness, and clarifies its mechanistic connection to oncogenic signaling.

2026-03-07 | GSE322668 | GEO

Circulating miR-22 predicts TACE response and targets WEE1 in hepatocellular carcinoma

Project description:Transarterial Chemoembolization (TACE) is the standard therapy for intermediate-stage liver cancer, yet high failure rates and a lack of early biomarkers remain significant challenges. Our study shows that circulating miR-22 levels increase significantly within 48 hours in TACE non-responders, providing a much faster alternative to traditional imaging for identifying treatment failure. Mechanistically, we identified the G2/M checkpoint kinase WEE1 as a direct functional target of miR-22. The miR-22/WEE1 axis has been identified as both a reliable predictor of outcomes and a potential target for personalized therapeutic interventions.

2026-05-06 | GSE327216 | GEO

An open-label, single-arm, prospective study of TACE combined with apatinib for unresectable liver metastases from colorectal cancer

Project description:Interventions: Treatment group:TACE combined with apatinib Primary outcome(s): time to progression Study Design: Non randomized control

| 2671010 | ecrin-mdr-crc

Comparison of TACE alone versus TACE combined with synchronous ablation for neuroendocrine neoplasms with liver metastases.

Project description: Not available

| S-EPMC12331546 | biostudies-literature

Efficacy, safety, and biomarker analysis of TACE combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a real-world study.

Project description: Not available

| S-EPMC11538227 | biostudies-literature

The study of TACE combined with apatinib for unresectable liver metastasis after colorectal cancer surgery

Project description:Interventions: Case series:TACE combined with apatinib Primary outcome(s): time to progression Study Design: Non randomized control

| 2677541 | ecrin-mdr-crc

Whole-transcriptome sequencing of hepatocellular carcinoma biopsies (TACE study)

Project description:We performed a transcriptomic analysis of hepatocellular carcinomas (HCCs) and paired non-tumor biopsies to identify predictive biomarkers for response to transarterial chemoembolization (TACE). We identified several transcripts which are predictive of response to TACE.

| EGAS00001005558 | EGA

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data